Tennessee HB1242 amends state law to protect 340B entities from interference in their drug acquisition and delivery.
Tennessee HB1242 amends state law to safeguard 340B entities from interference in their drug acquisition and delivery. The bill prohibits drug manufacturers and their affiliates from denying, restricting, or limiting the acquisition or delivery of 340B drugs to these entities. It also prevents interference with 340B entities' choice of drugs, contracts, and business relationships. Violations of these provisions are subject to civil penalties of up to $50,000 per violation. The act takes effect July 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.